Cancer Research Institute funds postdoctoral researcher Georgia Lattanzi

Georgia Lattanzi, PhD, a researcher in the lab of Daniel Hollern, PhD, was awarded funding for her project investigating how tiny particles released by tumor cells activate B cells to coordinate stronger, more comprehensive immune attacks. CRI recognizes the next generation of cancer immunotherapy innovations, investing in future scientific leaders such as Lattanzi who have the capacity to transform cancer care and research.